Difficult decision making in the management of patients with atrial fibrillation and acute coronary syndrome or invasive cardiovascular interventions: New recommendations for daily practice

Europace

Volumn 17, Issue 9, 2015, Pages 1319-1322

  Boriani, Giuseppe ^a   Lane, Deirdre A ^b   Windecker, Stephan ^c   Huber, Kurt ^d   Kirchhof, Paulus ^b,e   Lip, Gregory Y H ^b  

^a UNIVERSITY OF BOLOGNA   (Italy)

^b UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^c UNIVERSITY OF BERN   (Switzerland)

^d WILHELMINEN HOSPITAL   (Austria)

^e UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; ANTITHROMBOCYTIC AGENT; ANTIVITAMIN K; FIBRINOLYTIC AGENT;

ACUTE CORONARY SYNDROME; ANTICOAGULANT THERAPY; ATRIAL FIBRILLATION; BRAIN ISCHEMIA; CLINICAL ASSESSMENT; CLINICAL DECISION MAKING; CLINICAL PRACTICE; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; HUMAN; INTERNATIONAL NORMALIZED RATIO; MEDICAL HISTORY; MEDICAL SOCIETY; PATIENT CARE; PATIENT REFERRAL; PERCUTANEOUS CORONARY INTERVENTION; PHYSICIAN ATTITUDE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; STENT THROMBOSIS; TEAMWORK; TREATMENT DURATION; TREATMENT INDICATION; VASCULAR DISEASE; PROCEDURES; TRANSCATHETER AORTIC VALVE IMPLANTATION;

ACUTE CORONARY SYNDROME; ANTICOAGULANTS; ATRIAL FIBRILLATION; FIBRINOLYTIC AGENTS; HUMANS; PERCUTANEOUS CORONARY INTERVENTION; TRANSCATHETER AORTIC VALVE REPLACEMENT;

EID: 84939639370     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/euu303     Document Type: Review

References (18)

1. Boriani G, Diemberger I, Biffi M, Martignani C. Balancing the risk of hemorrhage vs thromboembolism in patients with atrial fibrillation: how to navigate between Scylla and Charybdis Chest 2010;138:1032-3.
2. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH et al. 2012 focused update of the ESC Guidelines for the management of atrial fibrillation: an update of the 2010 ESC Guidelines for the management of atrial fibrillation. Developed with the special contribution of the European Heart RhythmAssociation. Europace 2012;14:1385-413.
3. LipGY, Windecker S, Huber K, Kirchhof P, Marin F, Ten Berg JM et al. Management of antithrombotic therapy in atrial fibrillation patients presenting with acute coronary syndrome and/or undergoing percutaneous coronary or valve interventions: a joint consensus document of the European Society of Cardiology Working Group on Thrombosis, European Heart Rhythm Association (EHRA), European Association of Percutaneous Cardiovascular Interventions (EAPCI) and European Association of Acute Cardiac Care (ACCA) endorsed by the Heart Rhythm Society (HRS) and Asia-Pacific Heart Rhythm Society (APHRS). Eur Heart J 2014;35:3155-79.
4. Gorenek B, Blomström Lundqvist C, Brugada Terradellas J, Camm AJ, Hindricks G, Huber K et al. Cardiac arrhythmias in acute coronary syndromes: position paper from the joint EHRA, ACCA, and EAPCI task force. Europace 2014;16:1655-73.
5. Boriani G, Cervi E, Diemberger I, Martignani C, Biffi M. Clinical management of atrial fibrillation: need for a comprehensive patient-centered approach. Chest 2011;140: 843-5.
6. Kirchhof P, Lip GY, Van Gelder IC, Bax J, Hylek E, Kaab S et al. Comprehensive risk reduction in patients with atrial fibrillation: emerging diagnostic and therapeutic options-a report from the 3rd Atrial Fibrillation Competence NETwork/European Heart Rhythm Association consensus conference. Europace 2012;14:8-27.
7. Kirchhof P, Breithardt G, Aliot E, Al Khatib S, Apostolakis S, Auricchio A et al. Personalized management of atrial fibrillation: Proceedings from the fourth Atrial Fibrillation competence NETwork/European Heart Rhythm Association consensus conference. Europace 2013;15:1540-56.
8. Boriani G. Predicting the quality of anticoagulation during warfarin therapy: the basis for an individualized approach. Chest 2013;144:1437-8.
9. Apostolakis S, Sullivan RM, Olshansky B, Lip GY. Factors affecting quality of anticoagulation control among patients with atrial fibrillation on warfarin: the SAMe-TT2R2 score. Chest 2013;144:1555-63.
10. Lip GY. Stroke and bleeding risk assessment in atrial fibrillation: when, how, and why Eur Heart J 2013;34:1041-9.
11. Gallego P, Roldan V, Maŕn F, Romera M, ValdésM, Vicente V et al. Cessation of oral anticoagulation in relation to mortality and the risk of thrombotic events in patients with atrial fibrillation. Thromb Haemost 2013;110:1189-98.
12. De Caterina R, Husted S, Wallentin L, Andreotti F, Arnesen H, Bachmann F et al. Vitamin K antagonists in heart disease: current status and perspectives (Section III). Position paper of the ESC Working Group on Thrombosis-Task Force on Anticoagulants in Heart Disease. Thromb Haemost 2013;110:1087-107.
13. Desai J, Kolb JM, Weitz JI, Aisenberg J. Gastrointestinal bleeding with the new oral anticoagulants-defining the issues and the management strategies. Thromb Haemost 2013;110:205-12.
14. Lip GYH, Laroche C, Boriani G, Dan G-A, Santini M, Kalarus Z et al. Regional differences in presentation and treatment of patients with atrial fibrillation in Europe: a report from the EURObservational Research Programme Atrial Fibrillation (EORP-AF) Pilot General Registry. Europace 2015;17:194-206.
15. Lip GY, Laroche C, Dan GA, Santini M, Kalarus Z, Rasmussen LH et al. 'Real-world' antithrombotic treatment in atrial fibrillation: The EORP-AF pilot survey. Am J Med 2014;127:519-29.e1.
16. Azoulay L, Dell'Aniello S, Simon T, Renoux C, Suissa S. The concurrent use of antithrombotic therapies and the risk of bleeding in patients with atrial fibrillation. Thromb Haemost 2013;109:431-9.
17. Bernard A, Fauchier L, Pellegrin C, Clementy N, Saint Etienne C, Banerjee A et al. Anticoagulation in patients with atrial fibrillation undergoing coronary stent implantation. Thromb Haemost 2013;110:560-8.
18. Boriani G, Maniadakis N, Auricchio A, Müller-Riemenschneider F, Fattore G, Leyva F et al. Health technology assessment in interventional electrophysiology and device therapy: a position paper of the European Heart Rhythm Association. Eur Heart J 2013;34:1869-74.